does pfizer make glp 1 drugs pulls out of GLP-1 race after safety concerns PDB-101: Molecule of the Month:

"The potential increase was smallfewer than one additional case per 2,000 GLP-1RA users, while these medications have very well-established benefits for diabetes, obesity, and heart and kidney health

These expirations threaten Pfizers revenue, although the company has moved to counter the trend through a series of aggressive M&A deals including Seagen (ADC specialist), Trillium Therapeutics (oncology), Biohaven (neurology), Global Blood Therapeutics (rare diseases), and Arena Pharmaceuticals (immunology and inflammation)

Work with your doctor to create a testing schedule that fits your needs

People with obesity or overweight (without diabetes) In this case, it is considered an off-label use

T2D: type 2 diabetes

Also noted in Table 2 , several GLP-1 RAs have demonstrated favorable effects on secondary kidney outcomes